Xeljanz Medication Information

The U.S. Food and Drug Administration (FDA) has approved Xeljanz® (tofacitinib) to treat symptoms of moderate-to-severe active rheumatoid arthritis in adults. It comes as a tablet that is usually taken once or twice a day. Side effects are common and may include headaches, diarrhea, and infections.
 
If your healthcare provider recommends treatment with Xeljanz, he or she will need information on your medical history and any other medications, vitamins, or supplements you are using. Reviewing these details can help to minimize your risk for potentially dangerous drug interactions or other serious complications. For example, Xeljanz may not be safe for people who have problems with their liver or kidneys.
 
(To learn more about this medication, click Xeljanz. This full-length article covers more information, including details on how the drug works, what to expect during treatment, and other important warnings and precautions.)
 
 

Xeljanz Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.